Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Relationship between elevated levels of the alpha 1 acid glycoprotein in chronic myelogenous leukemia in blast crisis and pharmacological resistance to imatinib (Gleevec) in vitro and in vivo.
Larghero J, Leguay T, Mourah S, Madelaine-Chambrin I, Taksin AL, Raffoux E, Bastie JN, Degos L, Berthaud P, Marolleau JP, Calvo F, Chomienne C, Mahon FX, Rousselot P. Larghero J, et al. Biochem Pharmacol. 2003 Nov 15;66(10):1907-13. doi: 10.1016/s0006-2952(03)00469-6. Biochem Pharmacol. 2003. PMID: 14599548
Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: results of a multicenter phase II study on 25 patients.
Kérob D, Porcher R, Vérola O, Dalle S, Maubec E, Aubin F, D'Incan M, Bodokh I, Boulinguez S, Madelaine-Chambrin I, Mathieu-Boue A, Servant JM, de Kerviler E, Janin A, Calvo F, Pedeutour F, Lebbe C. Kérob D, et al. Among authors: madelaine chambrin i. Clin Cancer Res. 2010 Jun 15;16(12):3288-95. doi: 10.1158/1078-0432.CCR-09-3401. Epub 2010 May 3. Clin Cancer Res. 2010. PMID: 20439456 Free article. Clinical Trial.
Value of cytogenetic analysis in the treatment of dermatofibrosarcoma protuberans.
Kerob D, Pedeutour F, Leboeuf C, Verola O, de Kerviler E, Servant JM, Sarandi F, Bousquet G, Madelaine-Chambrin I, Pruvost C, Calvo F, Janin A, Lebbe C. Kerob D, et al. J Clin Oncol. 2008 Apr 1;26(10):1757-9. doi: 10.1200/JCO.2007.14.7330. J Clin Oncol. 2008. PMID: 18375907 No abstract available.
Autoimmune diabetes induced by PD-1 inhibitor-retrospective analysis and pathogenesis: a case report and literature review.
Gauci ML, Laly P, Vidal-Trecan T, Baroudjian B, Gottlieb J, Madjlessi-Ezra N, Da Meda L, Madelaine-Chambrin I, Bagot M, Basset-Seguin N, Pages C, Mourah S, Boudou P, Lebbé C, Gautier JF. Gauci ML, et al. Among authors: madelaine chambrin i. Cancer Immunol Immunother. 2017 Nov;66(11):1399-1410. doi: 10.1007/s00262-017-2033-8. Epub 2017 Jun 20. Cancer Immunol Immunother. 2017. PMID: 28634815 Free PMC article. Review.
Focal necrotizing myopathy with 'dropped-head syndrome' induced by cobimetinib in metastatic melanoma.
Gauci ML, Laly P, Leonard-Louis S, Behin A, Gottlieb J, Madelaine-Chambrin I, Baroudjian B, Da-Meda L, Mourah S, Battistella M, Basset-Seguin N, Bagot M, Pages C, Vercellino L, Maisonobe T, Lebbé C. Gauci ML, et al. Among authors: madelaine chambrin i. Melanoma Res. 2017 Oct;27(5):511-515. doi: 10.1097/CMR.0000000000000377. Melanoma Res. 2017. PMID: 28692456
Occurrence of type 1 and type 2 diabetes in patients treated with immunotherapy (anti-PD-1 and/or anti-CTLA-4) for metastatic melanoma: a retrospective study.
Gauci ML, Boudou P, Baroudjian B, Vidal-Trecan T, Da Meda L, Madelaine-Chambrin I, Basset-Seguin N, Bagot M, Pages C, Mourah S, Resche-Rigon M, Pinel S, Sassier M, Rouby F, Eftekhari P, Lebbé C, Gautier JF. Gauci ML, et al. Among authors: madelaine chambrin i. Cancer Immunol Immunother. 2018 Aug;67(8):1197-1208. doi: 10.1007/s00262-018-2178-0. Epub 2018 May 28. Cancer Immunol Immunother. 2018. PMID: 29808365 Free PMC article.
23 results